Login / Signup

Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies.

Sathej GopalakrishnanRajeev MenonAhmed A SuleimanArnon P KaterStephan StilgenbauerJohn F SeymourBrenda ChylaTong LuSu Young KimAndrew W RobertsJennifer A WoyachSven MensingAhmed Hamed Salem
Published in: HemaSphere (2023)
Keyphrases
  • chronic lymphocytic leukemia
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • hodgkin lymphoma
  • diffuse large b cell lymphoma
  • phase iii
  • randomized controlled trial
  • open label